Sino‐nasal outcome test–22: Cross‐cultural adaptation and validation in Russian speaking patients

Eisenbach, Netanel; Matot, Sofi; Nemet, Achia; Sela, Eyal; Marshak, Tal; Ronen, Ohad

doi:10.1111/coa.13505

Cited by 12 publications

(7 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, a strong correlation was obtained between the scores of the initial test and the retest examination. These results are in accordance with the results presented by others [11,20,21]. According to the results of our study, the Finnish version of the SNOT-22 questionnaire is also capable of measuring changes in patients' HRQoL after surgical intervention.…”

Section: Discussionsupporting

confidence: 93%

“…Comparing the numbers alone is not reasonable, due to putatively different extent of both disease and surgery performed. However, in all these studies the SNOT-22 was able to detect clinical changes over time [11,20,21].…”

Section: Discussionmentioning

confidence: 97%

“…To be successful, the validation process requires a systematic approach to the translation and crosscultural adaptation. To date SNOT-22 has been translated and validated in several languages e.g., Spanish, Russia, Arabic, Italian and Danish [8][9][10][11][12].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Translation, cross-cultural adaptation, and validation of the sino-nasal outcome test (snot)-22 for Finnish patients

Koskinen

Hammarén‐Malmi

Myller

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Purpose The Sino-Nasal Outcome Test-22 (SNOT-22) is the most commonly used disease-specific quality of life questionnaire in rhinology. The purpose of this prospective study was to translate and validate SNOT-22 into Finnish. Methods The validation process followed the guidelines proposed for cross-cultural adaptation of health-related measures of quality of life. The study consisted of three groups: rhinologic out-patients (N = 96), FESS patients (N = 49) and healthy controls (N = 79). Out-patient and FESS groups completed the questionnaire twice (answers A and B), out-patients after two weeks and FESS patients after 3 months. Validity, reliability and responsiveness were evaluated. Results The mean SNOT-22 sum score of the out-patient questionnaires were 35.3 points (answer A) and 32.4 points (answer B). ICC in out-patient group was 0.879. For the FESS patients, the mean pre- and postoperative (answer A and B) SNOT-22 sum scores were 46.8 and 21.9 points, respectively (p < 0.0001). The mean SNOT-22 of healthy controls was 8.9 points. The out-patients (answer A) and healthy controls had statistically significant difference in SNOT-22 scores (p < 0.0001). Conclusions The results of our study show that the validated Finnish version of the SNOT-22 questionnaire demonstrates good validity, reliability and responsiveness.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Translation, cross-cultural adaptation, and validation of the sino-nasal outcome test (snot)-22 for Finnish patients

Koskinen

Hammarén‐Malmi

Myller

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…11 We used the version of the SNOT-22, which was validated and adapted to the Russian language by Eisenbach et al (hereinafter, rSNOT-22). 12…”

Section: Subjective Assessment Of Smellmentioning

confidence: 99%

Smell Status in Children Infected with SARS‐CoV‐2

et al. 2021

View full text Add to dashboard Cite

Objectives/Hypothesis This study aimed to evaluate the olfactory status in children with laboratory confirmed SARS‐CoV‐2 using subjective and psychophysical methods. Study Design Prospective clinical cross‐sectional study. Methods This is a prospective clinical cross‐sectional study of 79 children with COVID‐19. The 21st item of SNOT‐22 questionnaire and odor identification test were used for smell assessment. Children were examined twice during the hospitalization, and a telephone survey was conducted 60 days after hospital discharge. Results Immediately after confirmation of COVID‐19, smell impairment was detected in 86.1% of children by means of the Identification test and in 68.4% of children by means of the survey ( P = .010). After 5 days survey revealed a statistically significant decrease in the number of patients with hyposmia (41 out of 79, 51.9%). On the first visit, the mean Identification test score corresponded to “hyposmia” (9.5 ± 2.7), while on the second visit, the average value was 13.1 ± 1.9, which corresponded to “normosmia.” According to the telephone survey, recovery of the olfactory function occurred within 10 days in 37 of 52 patients (71.2%), 11 to 29 days ‐ in 12 children (23.1%), and later than 30 days ‐ in three cases (5.7%). Conclusions In the pediatric population, olfactory dysfunction is an early and common symptom of COVID‐19. There is a trend to quick recovery of olfactory function in children with COVID‐19. The overwhelming majority of patients (94.3%) had no subjective olfactory complaints by the end of the first month. Level of Evidence 4 Laryngoscope , 2021

show abstract

“…Each item quantifies the severity of the symptom from 0 (no problem) to 5 (worst possible symptom), resulting in a maximum total questionnaire score of 110. To date, it has been adapted and validated in several other languages [9][10][11][12][13][14][15][16][17][18][19][20]. The translation and validation of the questionnaire was initiated by the Working Group for Rhinology (ARHIN) of the German Society for Otorhinolaryngology, Head and Neck Surgery, to enable international multicenter studies including German study sites and to compare the burden of disease internationally.…”

Section: Introductionmentioning

confidence: 99%

Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study

Albrecht

Beule

Hildenbrand

et al. 2021

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Purpose Chronic rhinosinusitis (CRS) is a common condition associated with a significant reduction of the health-related quality of life. One of the most widely used assessment tools in CRS is the disease-specific, health-related questionnaire SNOT-22. The aim of this study was to translate and validate the SNOT-22 into the German language. Methods The questionnaire was translated using the forward–backward translation technique. After the translation its reliability, validity, and sensitivity were evaluated. For this purpose, the questionnaire was completed by patients diagnosed with CRS before, 3 months and 1 year after endoscopic sinus surgery and by healthy individuals as controls at three university hospitals in Germany. The individual scores of the questionnaire before surgery was correlated with the Lund–Mackay score as well as a global disease-specific question. Results A total of 139 CRS patients and 31 healthy individuals participated in the study. Internal consistency at all timepoints was very good, with Cronbach’s alpha scores of 0.897, 0.941, and 0.945. The questionnaire was able to discriminate between CRS patients and control subjects (p < 0.0001) and scores improved significantly 3 month and 1 year after sinus surgery (p < 0.0001), indicating a good test–retest reliability, validity, and responsiveness. A significant correlation to the single global disease-specific question could be found (p < 0.0001), but no correlation with the Lund–Mackay score. Conclusion The German Version of the SNOT-22 is a reliable, valid, and sensitive instrument for measuring health-related quality of life in patients with CRS. It can be recommended for clinical practice and outcome research for German-speaking patients.

show abstract

Sino‐nasal outcome test–22: Cross‐cultural adaptation and validation in Russian speaking patients

Cited by 12 publications

References 27 publications

Translation, cross-cultural adaptation, and validation of the sino-nasal outcome test (snot)-22 for Finnish patients

Translation, cross-cultural adaptation, and validation of the sino-nasal outcome test (snot)-22 for Finnish patients

Smell Status in Children Infected with SARS‐CoV‐2

Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study

Contact Info

Product

Resources

About